Aimia Inc.

OTCPK:AIMF.F Stock Report

Market Cap: US$169.8m

Aimia Valuation

Is AIMF.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AIMF.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AIMF.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AIMF.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AIMF.F?

Key metric: As AIMF.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AIMF.F. This is calculated by dividing AIMF.F's market cap by their current revenue.
What is AIMF.F's PS Ratio?
PS Ratio0.5x
SalesCA$437.10m
Market CapCA$237.31m

Price to Sales Ratio vs Peers

How does AIMF.F's PS Ratio compare to its peers?

The above table shows the PS ratio for AIMF.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.4x
FTK Flotek Industries
1.4x13.5%US$241.4m
NANX Nanophase Technologies
3.9xn/aUS$185.2m
ARQ Arq
3x18.4%US$330.4m
NTIC Northern Technologies International
1.6x8.1%US$132.5m
AIMF.F Aimia
0.5x11.3%US$237.3m

Price-To-Sales vs Peers: AIMF.F is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (2.4x).

Price to Sales Ratio vs Industry

How does AIMF.F's PS Ratio compare vs other companies in the US Chemicals Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.04x5.0%US$125.68m
ALTO Alto Ingredients
0.1x3.1%US$108.84m
BON Bon Natural Life
0.2xn/aUS$6.23m
ABLT American Biltrite
0.02xn/aUS$2.91m
AIMF.F 0.5xIndustry Avg. 1.4xNo. of Companies17PS01.22.43.64.86+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AIMF.F is good value based on its Price-To-Sales Ratio (0.5x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is AIMF.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AIMF.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: AIMF.F is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AIMF.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1.77
US$2.96
+67.4%
3.0%US$3.05US$2.87n/a2
Aug ’25US$1.94
US$3.12
+61.0%
5.9%US$3.31US$2.94n/a2
Jul ’25US$1.98
US$3.12
+58.1%
5.9%US$3.31US$2.94n/a2
Jun ’25US$2.06
US$3.12
+51.6%
5.9%US$3.31US$2.94n/a2
May ’25US$1.71
US$3.13
+83.7%
5.9%US$3.32US$2.95n/a2
Apr ’25US$1.91
US$3.13
+63.8%
5.9%US$3.32US$2.95n/a2
Mar ’25US$2.28
US$3.74
+64.3%
2.4%US$3.83US$3.65n/a2
Feb ’25US$2.51
US$3.74
+49.1%
2.4%US$3.83US$3.65n/a2
Jan ’25US$2.36
US$3.74
+58.6%
2.4%US$3.83US$3.65n/a2
Dec ’24US$2.21
US$3.74
+69.2%
2.4%US$3.83US$3.65n/a2
Nov ’24US$2.31
US$3.99
+72.7%
2.3%US$4.08US$3.90US$1.802
Oct ’24US$2.28
US$3.99
+75.1%
2.3%US$4.08US$3.90US$1.932
Sep ’24US$2.32
US$3.99
+72.2%
2.3%US$4.08US$3.90US$1.962
Aug ’24US$2.43
US$4.15
+71.0%
6.7%US$4.43US$3.87US$1.942
Jul ’24US$2.49
US$4.15
+66.7%
6.7%US$4.43US$3.87US$1.982
Jun ’24US$2.67
US$4.15
+55.5%
6.7%US$4.43US$3.87US$2.062
May ’24US$2.60
US$4.10
+57.5%
6.7%US$4.37US$3.82US$1.712
Apr ’24US$2.69
US$4.10
+52.3%
6.7%US$4.37US$3.82US$1.912
Mar ’24US$3.03
US$4.41
+45.5%
2.1%US$4.51US$4.32US$2.282
Feb ’24US$2.70
US$4.41
+63.3%
2.1%US$4.50US$4.32US$2.512
Jan ’24US$2.70
US$4.41
+63.3%
2.1%US$4.50US$4.32US$2.362
Dec ’23US$2.64
US$4.41
+67.0%
2.1%US$4.50US$4.32US$2.212

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Trinseo

US$125.7m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.55

7D

2.6%

1Y

-45.6%

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.82

7D

-4.5%

1Y

-28.7%

Allied Gold

CA$1.1b

Explores for and produces mineral deposits in Africa.

AAUC.F

CA$2.47

7D

16.0%

1Y

-18.0%